CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 126 enrolled
Drug / intervention
PARIETEX™ Composite Ventral Patchdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01848184
NCT01848184N/ACompleted
CompareCT.gov

A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patch - Panacea Study.

Medtronic - MITG·observational·Posted May 7, 2013·Updated Jul 20, 2018

In Brief

An observational study evaluating PARIETEX™ Composite Ventral Patch for Hernia. Completed, enrolled 126 participants across 10 sites in 4 countries.

Detailed Summary

The objective of this study is to assess the recurrence rate following the use of PARIETEX™ Composite Ventral Patch in primary ventral hernia repair by open approach with intra-peritoneal positioning.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHernia
CountriesBelgium, Denmark, Sweden, United States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 7, 2013
Enrollment StartMay 1, 2013
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 13.2 years ago

Interventions

PARIETEX™ Composite Ventral Patchdevice

PARIETEX™ Composite Ventral Patch for ventral hernia repair